Every Form 4 that Transact Technologies Inc (TACT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow TACT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full TACT filings page.
TransAct Technologies reported that President and CEO John Dillon had 12,050 restricted stock units, granted on August 3, 2023 under the company’s 2014 Equity Incentive Plan, vest and convert one-for-one into 12,050 shares of common stock on August 3, 2026. Following this conversion, he holds 180,368 shares directly and 100,000 shares indirectly through a trust.
TransAct Technologies Inc. reported that CFO, Treasurer and Secretary Troy W. Ingianni received a grant of 15,000 Restricted Stock Units (RSUs) on July 1, 2026 under the company’s 2014 Equity Incentive Plan, as Amended and Restated. The RSUs vest 25% annually starting on the first anniversary of the grant date and convert into common stock on a one-for-one basis as they vest. Following this compensation award, Ingianni holds 15,000 RSUs directly.
TransAct Technologies President and CFO Steven A. DeMartino exercised 41,747 Performance Stock Units into an equal number of common shares on June 30, 2026. To cover taxes, 16,422 common shares were disposed of through tax withholding, not an open-market sale. Following these compensation-related transactions, DeMartino directly holds 228,016 shares of common stock. The Performance Stock Units were originally granted on May 1, 2025 under the company’s 2014 Equity Incentive Plan and vested pursuant to a Separation Agreement and General Release dated May 7, 2026.
TRANSACT TECHNOLOGIES INC President and CFO Steven A. DeMartino reported routine equity compensation activity involving restricted stock units (RSUs) and related tax withholding. On June 4, 2026, 12,500 RSUs converted into an equal number of common shares at a stated price of $0.00 per share, consistent with an equity award granted on September 4, 2024 under the company’s 2014 Equity Incentive Plan. To cover tax obligations, 4,291 common shares were disposed of at $4.66 per share as a tax-withholding transaction, not an open‑market sale. Following these transactions, he continues to hold over 200,000 common shares directly.
TransAct Technologies insiders associated with 325 Capital report the conversion of 1,700 Restricted Stock Units into common stock. These RSUs were issued on May 4, 2022 under the company’s 2014 Equity Incentive Plan and convert to common shares on a one-for-one basis as they vest 25% annually.
The 1,700 RSUs, granted to director Daniel M. Friedberg, have increased his indirectly reported common stock position to 17,800 shares. Separately, 325 Capital Master Fund LP directly owns 1,011,789 common shares. The filing is made jointly by 325 Capital entities and individuals who may be deemed to share a pecuniary interest in these securities, while each disclaims beneficial ownership beyond that interest.
TransAct Technologies President and CFO Steven A. DeMartino reported routine equity compensation activity. On May 1, 2026, 10,100 restricted stock units vested and converted into an equal number of common shares at a stated price of $0.00 per share.
To cover tax obligations, 3,467 common shares were disposed of at $3.32 per share through a tax-withholding mechanism, not an open-market sale. After these transactions, DeMartino held 194,482 shares of TransAct common stock directly. The related restricted stock units were issued under the company’s 2014 Equity Incentive Plan and vest 25% annually.
TRANSACT TECHNOLOGIES INC director Audrey Dunning exercised equity awards to receive additional common shares. On May 4, 2026, 1,700 Restricted Stock Units granted on May 4, 2022 under the company’s 2014 Equity Incentive Plan converted into 1,700 shares of common stock on a one-for-one basis. Following this vesting and conversion, she directly holds 19,300 shares of common stock. The RSUs were compensation-related awards that vested annually and did not involve an open-market purchase or sale.
TRANSACT TECHNOLOGIES INC Chief Technology Officer Brent Richtsmeier reported a routine equity compensation event. On May 1, 2026, 6,325 Restricted Stock Units converted into an equal number of common shares at no exercise price, reflecting vesting under the company’s 2014 Equity Incentive Plan.
Following the conversion, he directly holds 36,323 shares of common stock and 18,975 Restricted Stock Units. The RSUs were originally issued on May 1, 2025 and vest 25% each year starting on the first anniversary of the grant date.
TransAct Technologies CEO John Dillon reported open-market purchases of company stock through a trust. A trust associated with him bought 29,098 shares of common stock on March 13 at a weighted average price of $3.56 per share, in multiple trades between $3.30 and $3.60. On March 16, the trust bought an additional 70,902 shares at a weighted average price of $3.49, in trades between $3.39 and $3.60, bringing the trust’s indirect holdings to 100,000 shares. Dillon also directly owns 168,318 shares of common stock, which now reflects an extra 1,100 shares that had been omitted from earlier filings due to an administrative error.
TransAct Technologies filed an amended Form 4 to correct a director equity award. On February 24, 2026, Daniel M. Friedberg received a grant of 15,759 Restricted Stock Units under the 2014 Equity Incentive Plan, rather than the 14,700 units previously reported.
The RSUs cliff vest on the first anniversary of the grant and convert into common stock on a one-for-one basis. 325 Capital LLC is entitled to the economic interest in securities granted for Mr. Friedberg’s board service, and multiple affiliated entities may be deemed to share beneficial ownership, which they each disclaim except for any pecuniary interest.
TransAct Technologies director Emanuel N. Hilario corrected a previously reported equity award. An amended Form 4 now shows he received a grant of 15,759 Restricted Stock Units on February 24, 2026, replacing the originally reported 14,700 units. These RSUs cliff vest on the first anniversary of the grant and convert into common stock on a one-for-one basis. Following this correction, his reported RSU holdings from this grant total 15,759 units.
TransAct Technologies director Haydee Olinger received a corrected equity grant. An amended Form 4 now shows a grant of 15,759 Restricted Stock Units on February 24, 2026, instead of the 14,700 units previously reported. These RSUs cliff vest on the first anniversary of the grant and convert into common stock on a one-for-one basis.
TransAct Technologies director Randall S. Friedman received a grant of 15,759 Restricted Stock Units on February 24, 2026 as equity compensation. This Form 4 amendment corrects an earlier report that mistakenly showed 14,700 units. The RSUs were issued under the company’s 2014 Equity Incentive Plan, as amended and restated.
The units cliff vest on the first anniversary of the grant date and then convert into common stock on a one-for-one basis. Following this grant, Friedman is reported as directly holding 15,759 Restricted Stock Units tied to TransAct common stock.
TransAct Technologies director Audrey Dunning received a grant of 15,759 Restricted Stock Units on February 24, 2026 under the company’s 2014 Equity Incentive Plan, as Amended and Restated. This Form 4/A corrects an earlier filing that had mistakenly reported 14,700 units.
The RSUs cliff vest on the first anniversary of the grant date and will convert into an equal number of common shares on a one-for-one basis. Following this award, Dunning directly holds 15,759 RSUs, reflecting a compensation-related equity grant rather than an open‑market share purchase or sale.
TRANSACT Technologies President and CFO Steven A. DeMartino reported equity award activity involving restricted stock units and common stock. On March 4, 2026, he exercised 12,500 restricted stock units, which converted into 12,500 shares of common stock at a stated price of $0.0000 per share.
The restricted stock units were originally issued on September 4, 2024 under the company’s 2014 Equity Incentive Plan, vesting in eight equal quarterly installments over two years. After the conversion, DeMartino held 25,000 restricted stock units and 192,089 shares of common stock directly.
To cover tax obligations related to the award, 4,240 shares of common stock were disposed of in a tax-withholding transaction coded “F” at $3.4800 per share. Following these transactions, DeMartino’s direct ownership stood at 187,849 shares of common stock.
TransAct Technologies Inc. insiders reported indirect acquisitions of common stock through restricted stock unit (RSU) conversions. On February 27–March 1, 2026, RSUs previously granted under the company’s 2014 Equity Incentive Plan were exercised or converted into common shares at $0.00 per share under code M.
The transactions include RSUs issued on March 1, 2023, February 29, 2024, and February 27, 2025, each vesting 25% annually and converting to common stock on a one-for-one basis. Reported amounts include, for example, 2,850 and 1,675 common shares acquired indirectly.
The filing is made jointly by 325 Capital LLC, 325 Capital Master Fund LP, 325 Capital GP, LLC, and individuals including director Daniel M. Friedberg and Anil K. Shrivastava, who may be deemed to share pecuniary interests and beneficial ownership but each disclaims beneficial ownership except to the extent of any pecuniary interest.
TransAct Technologies director Haydee Olinger reported multiple equity award conversions into common stock. On February 27, 28 and March 1–2, 2026, Restricted Stock Units granted under the company’s 2014 Equity Incentive Plan converted to common stock on a one-for-one basis at a price of $0.00 per share.
The transactions reflect derivative exercises or conversions, increasing directly held common stock through vesting of prior RSU grants from 2022, 2023, 2024 and 2025, each vesting 25% annually starting on the first anniversary of grant.
TransAct Technologies director Emanuel N. Hilario reported acquiring a total of 7,375 shares of common stock through exercises of restricted stock units between February 27, 2026 and March 2, 2026 at a price of 0.00 per share. Each restricted stock unit converted into one share of common stock under the company’s 2014 Equity Incentive Plan, which provides for annual vesting starting one year after grant.
After these derivative exercises and conversions, Hilario directly owns 29,100 shares of TransAct Technologies common stock. These transactions reflect the vesting and settlement of equity awards rather than open‑market purchases or sales.
TransAct Technologies Inc. director Randall S. Friedman reported multiple stock award vestings that converted into common shares. On February 27, 28, March 1 and March 2, 2026, he exercised Restricted Stock Units into matching amounts of common stock at a price of $0.0000 per share.
The RSUs were originally granted between 2022 and 2025 under the company’s 2014 Equity Incentive Plan, vesting 25% annually and converting on a one-for-one basis into common stock. After these conversions, Friedman directly owned 21,800 shares of TransAct common stock, with no reported share sales.
TransAct Technologies director Audrey Dunning increased her direct common stock holdings through equity awards converting into shares. On February 27, February 28, and March 1, 2026, she exercised restricted stock units granted under the company’s 2014 Equity Incentive Plan, Amended and Restated, into common stock on a one-for-one basis at a reported price of $0.00 per share. Following these conversions, her directly owned common stock position is reported at 17,600 shares.
TransAct Technologies’ Chief Technology Officer Brent Richtsmeier reported a series of equity award conversions into common stock. On February 28 and March 1–2, he exercised vested restricted stock units and performance stock units, each converting to common stock on a one-for-one basis at a price of $0.00 per share. These were non‑cash transactions reflecting the vesting of awards under the company’s 2014 Equity Incentive Plan. Following the latest reported conversion on March 2, his direct ownership in common stock increased to 29,998 shares.
TransAct Technologies CEO John Dillon exercised previously granted Restricted Stock Units that vested under the company’s 2014 Equity Incentive Plan, converting 8,675 RSUs into the same number of common shares at a price of $0.00 per share.
After these derivative exercises and conversions on February 28, March 1, and March 2, Dillon directly owned 167,218 shares of common stock.
TransAct Technologies President and CFO Steven A. DeMartino reported multiple equity-award vesting events and related tax withholdings in late February and early March. On March 1, 2026, Performance Stock Units granted on March 1, 2023 converted into 7,629 shares of common stock, with some shares withheld to cover taxes. Restricted Stock Units granted in 2022, 2023 and 2024 also vested and converted one-for-one into common shares on February 28, March 1, and March 2, 2026. Several Form 4 entries coded “F” show shares delivered back to the company at prices around $3.46–$3.50 solely to satisfy tax or exercise obligations, rather than open-market sales, leaving DeMartino with a remaining direct holding of common stock.
TransAct Technologies Chief Marketing Officer Dana Loof reported an equity award of 14,124 Restricted Stock Units on February 25, 2026. These RSUs were granted under the company’s 2014 Equity Incentive Plan, vest in a single “cliff” tranche on the second anniversary of the grant, and then convert into common stock on a one-for-one basis.
TransAct Technologies reported that Chief Accounting Officer William DeFrances received a grant of 6,780 Restricted Stock Units on February 25, 2026. These RSUs were issued under the company’s 2014 Equity Incentive Plan, as Amended and Restated.
The award cliff vests on the second anniversary of the grant date and then converts into common stock on a one-for-one basis, aligning the executive’s compensation with future company performance. Following these transactions, his directly held common stock balance is reported as zero shares.
TransAct Technologies Chief Technology Officer Brent Richtsmeier reported an equity compensation grant. On February 25, 2026, he acquired 14,124 Restricted Stock Units under the company’s 2014 Equity Incentive Plan, as Amended and Restated. These RSUs vest 25% each year, starting on the first anniversary of the grant date.
Following this filing, his directly held common stock position is 21,695 shares, and his RSU holdings total 14,124 units, reflecting his long-term, equity-based compensation alignment with the company.
DILLON JOHN reported acquisition or exercise transactions in this Form 4 filing.
TRANSACT TECHNOLOGIES INC CEO John Dillon reported an equity award of 55,862 Restricted Stock Units on February 25, 2026. These RSUs were granted under the company’s 2014 Equity Incentive Plan, as Amended and Restated, and vest 25% each year starting on the first anniversary of the grant date.
Following this award, Dillon holds 55,862 Restricted Stock Units directly and 158,543 shares of common stock in direct ownership, aligning a significant portion of his compensation with the company’s future performance.
TransAct Technologies Inc Chief Revenue Officer Tracey S. Chernay received a grant of 14,124 Restricted Stock Units on February 25, 2026. The units were issued at no cash cost under the company’s 2014 Equity Incentive Plan, as Amended and Restated.
The RSUs cliff vest on the second anniversary of the grant date and then convert into common stock on a one-for-one basis. Following the grant, Chernay directly holds 14,124 RSUs and no shares of common stock are listed as directly owned after this transaction.
TransAct Technologies CEO John Dillon reported awards and vesting of performance-based equity. On February 24, 2026, he was granted 177,320 Performance Stock Units (PSUs) at no cost under the company’s 2014 Equity Incentive Plan. The PSUs were originally issued on May 1, 2025 and vest in three equal installments on February 24, 2026, 2027, and 2028.
On the same date, 59,106 PSUs were exercised and converted into 59,106 shares of common stock on a one-for-one basis, also at no cost. These PSUs were earned based on 2025 Revenue and Adjusted EBITDA performance, with a payout level of 155%. After these transactions, Dillon directly held 158,543 shares of common stock and 118,213 PSUs.
TransAct Technologies President and CFO Steven A. DeMartino reported equity award activity involving performance stock units (PSUs) and common stock. He received a grant of 62,620 PSUs at no cost and exercised 20,873 PSUs that converted into an equal number of common shares on a one-for-one basis. Following these transactions, he directly held 170,847 shares of common stock and 41,747 PSUs. A separate disposition of 7,082 common shares at $3.49 per share was made to cover tax liabilities related to the award, rather than an open-market sale. The PSUs were issued under the company’s 2014 Equity Incentive Plan and vest in three equal installments on February 24, 2026, February 24, 2027, and February 24, 2028, with the final payout level based on 2025 revenue and adjusted EBITDA performance at a 155% achievement level.
TransAct Technologies Chief Technology Officer Brent Richstmeier reported equity compensation activity tied to 2025 performance. On February 24, 2026, he received a grant of 39,215 Performance Stock Units (PSUs) that vest in three equal installments on February 24, 2026, 2027 and 2028. On the same date, 13,072 PSUs previously issued on May 1, 2025 converted into an equal number of common shares, reflecting a 155% payout based on 2025 revenue and Adjusted EBITDA results. To cover taxes related to this vesting, 3,879 common shares were disposed of at $3.49 per share, leaving Richstmeier with 21,695 common shares directly owned after these transactions.
TransAct Technologies director-affiliated entities reported an award of 14,700 restricted stock units on February 24, 2026. These RSUs were granted to director Daniel M. Friedberg under the company’s 2014 Equity Incentive Plan, cliff vest after one year, and convert into common stock on a one-for-one basis.
The filing is made jointly by 325 Capital LLC, 325 Capital Master Fund LP, 325 Capital GP, LLC, and individuals including Friedberg and Anil K. Shrivastava, who may be deemed to have a pecuniary interest. The group also reports indirect holdings of common stock through Friedberg and 325 Capital Master Fund, while disclaiming beneficial ownership except to the extent of any economic interest.
TRANSACT TECHNOLOGIES INC director Audrey Dunning received an equity grant in the form of restricted stock units. She was awarded 14,700 restricted stock units on February 24, 2026 as a grant or award. These units were issued under the company’s 2014 Equity Incentive Plan, as amended and restated.
The restricted stock units cliff vest on the first anniversary of the grant date and then convert into common stock on a one-for-one basis. After this filing, Dunning directly holds 11,475 shares of common stock, separate from the newly granted restricted stock units.
TransAct Technologies director Randall S. Friedman was awarded 14,700 Restricted Stock Units (RSUs) on February 24, 2026. The RSUs were granted under the company’s 2014 Equity Incentive Plan, as Amended and Restated, and will cliff vest on the first anniversary of the grant date, then convert into common stock on a one-for-one basis.
TransAct Technologies director Haydee Olinger reported an equity award consisting of 14,700 Restricted Stock Units granted on February 24, 2026 under the company’s 2014 Equity Incentive Plan. These RSUs cliff vest on the first anniversary of the grant and convert into common stock on a one-for-one basis. Olinger also reports direct ownership of 27,185 shares of common stock as of that date.
TransAct Technologies director Emanuel N. Hilario received a grant of 14,700 Restricted Stock Units on February 24, 2026. The RSUs were issued at a price of $0.00 per unit under the company’s 2014 Equity Incentive Plan, as amended and restated.
The award cliff vests on the first anniversary of the grant date and will convert into common stock on a one-for-one basis when vested. Following this award, Hilario directly holds 14,700 RSUs and 21,725 shares of common stock.
TransAct Technologies reported an equity grant to its Chief Marketing Officer, Dana Loof. On December 15, 2025, Loof received 15,000 Restricted Stock Units under the company’s 2014 Equity Incentive Plan, as Amended and Restated.
The restricted stock units cliff vest on the second anniversary of the grant date, meaning all 15,000 units vest at once two years after December 15, 2025. Upon vesting, each unit converts into one share of TransAct common stock on a one-for-one basis. Following this grant, Loof beneficially owns 15,000 derivative securities, held directly.
TransAct Technologies Inc. (TACT) officer Steven A. DeMartino, who serves as President, CFO, Treasurer and Secretary, reported a stock transaction involving company shares. On 11/17/2025, he sold 1,000 shares of TransAct common stock at a price of $4.30 per share. After this transaction, he directly owned 148,847 shares of TransAct common stock.
The filing also notes that an additional 1,000 shares owned by Mr. DeMartino had been inadvertently omitted from his prior filings due to an administrative error, and this report reflects that correction.